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This dissertation focuses on the directed self-assembly of nanoscale soft 
matter particles using methods based on liposome-templating.  Nanoscale liposomes, 
nano-sized hydrogel particles (“nanogels”), and hybrids of the two have enormous 
potential as carriers in drug delivery and nanotoxicity studies, and as nanovials for 
enzyme encapsulation and single molecule studies.  Our goal is to develop assembly 
methods that produce stable nanogels or hybrid lipid-polymer nanoparticles, using 
liposomes as size and shape templates.   
 
First we describe a bulk method that employs liposomes to template relatively 
monodisperse nanogels composed of the biopolymer, alginate, which is a favorable 
material for nanogel formation because it uses a gentle ionic crosslinking mechanism 
that is suitable for the encapsulation of cells and biomolecules.  Liposomes 
encapsulating sodium alginate are suspended in aqueous buffer containing calcium 
chloride, and thermal permeabilization of the lipid membrane facilitates 
transmembrane diffusion of Ca
2+
 ions from the surrounding buffer into the 
  
intraliposomal space, ionically crosslinking the liposome core.  Subsequent lipid 
removal results in bare calcium alginate nanogels with a size distribution consistent 
with that of their liposome template.  
 
The second part of our study investigates the potential for microfluidic-
directed formation of lipid-alginate hybrid nanoparticles by adapting the above bulk 
self-assembly procedure within a microfluidic device.  Specifically we investigated 
the size control of alginate nanogel self-assembly under different flow conditions and 
concentrations.  
 
Finally, we investigate the microfluidic directed self-assembly of lipid-
polymer hybrid nanoparticles, using phospholipids and an N-isopropylacrylamide 
monomer as the liposome and hydrogel precursors, respectively.  Microfluidic 
hydrodynamic focusing is used to control the convective-diffusive mixing of the two 
miscible nanoparticle precursor solutions to form nanoscale vesicles with 
encapsulated hydrogel precursor.  The encapsulated hydrogel precursor is 
polymerized off-chip and the resultant hybrid nanoparticle size distributions are 
highly monodisperse and precisely controlled across a broad range relevant to the 
targeted delivery and controlled release of encapsulated therapeutic agents.  Given the 
ability to modify liposome size and surface properties by altering the lipid 
components and the many polymers of current interest for nanoparticle synthesis, this 
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1. I!TRODUCTIO! A!D OVERVIEW 
 
1.1 PROBLEM DESCRIPTIO! A!D MOTIVATIO! 
This dissertation is focused on the templated assembly, characterization, and 
applications of soft nanoparticles derived from liposome and hydrogel precursors. 
Recently, the field of supramolecular chemistry has attracted increasing exploration. 
In particular, researchers have been applying the concept of self-assembly to develop 
new nano-based materials, constructing them from simple molecular building blocks 
via noncovalent (e.g. hydrophobic, electrostatic, hydrogen bonding) interactions
2-4
.  
Nanoparticles are currently a central research interest in biomedical, optical, and 
electronic fields due to their unique properties owing to their small size, high surface 
to volume ratio, and chemical composition
5,6
.  As a result, new classes of 
nanoparticles are continuously being investigated and developed to address the 
delivery needs for various biological applications.  A major barrier preventing the 
practical application of many nanoparticles is the lack of methods that can produce 
uniform populations in a relatively simple and reproducible manner.  This problem is 
most prevalent in clinical and toxicological studies, where accurate data concerning 
the physiological and environmental effects of nano-sized carriers is desperately 
needed
6,7
, but limited knowledge exists due to the differences between the preparation 
techniques applied.     
 
Nanoscale liposomes, well recognized for their drug delivery potential and 




molecules, and provide a relatively impermeable barrier in terms of controlled 
release.  However, the lipid bilayer is extremely susceptible to perturbations due to 
environmental changes in temperature, pH, or osmolarity, which is a disadvantage in 
therapeutics when considering the need for sustained release and prolonged 
circulation in the body.  Hydrogel nanoparticles offer greater mechanical stability 
compared to liposomes, and the three-dimensional structure offers a level of control 
for the release of an encapsulated biomolecule, but they are prone to degradation and 
aggregation, and lack the targeting properties of liposomes
8
.   
 
The intricate biological parameters that must be considered when designing a 
particulate delivery system has caused a natural progression towards the development 
of more complex hybrid nanoparticle systems that combine the advantages of 
multiple soft matter materials to produce more robust and versatile nanocarriers
9
.  In 
particular, by combining the liposome and hydrogel components, the resultant lipid-
polymer hybrid nanoparticles are equipped with the strengths of each of the single 
material systems while compensating for each of their weaknesses.  Such hybrid 
nanoparticles are increasingly becoming the focus of synthesis and characterization 
studies, due to their potential practical utility in drug delivery and life sciences 
research
9,10
.   
 
Lipid-polymer nanoparticles have been synthesized using bulk self-assembly 
methods.  One of the common bulk methods is to first synthesize the hydrogel 






.  A second method involves the use of liposomes as 
reaction vessels for the formation of the hydrogel core component.  Several groups 
have applied the latter method in bulk, using various lipid formulations and 
polymerization techniques, the majority of which have applied free radical 
polymerization of liposomes encapsulating synthetic monomers, crosslinking 
molecules with a low molecular weight, and photoinitiator formulations to form solid 
cores
13-16
.  Alternative approaches for hybrid nanoparticle formation include 
nanoprecipitation
9
 and solvent injection techniques. 
 
Beyond these bulk synthesis methods, relatively few microfluidic systems 
have been reported for the self-assembly of more complex hybrid nanoparticle 
systems, though they have been demonstrated to improve control over the continuous 
self-assembly of  single material polymeric and phospholipid nanoparticles
17-19
 
compared with bulk liposome preparation methods.  There is a need for similar 
reliable and simple synthesis methods that enable precise control over the self-
assembly of lipid-hydrogel hybrid nanoparticles, as their more complex structures 
generally require more elaborate synthesis methods
5,20
.  As nanoparticle size and 
shape are two critical properties that strongly affect the biological fate or toxicity of a 
particular carrier
5,21
, methods that produce homogeneous and versatile nanoparticle 
systems using simple and preferably automated processes are necessary for working 





1.2 OUR APPROACH 
Our goal is to develop synthesis methods that demonstrate size and structure 
control over the resultant nanoparticle populations, and to this end we implement 
liposomes as nanotemplates for the self-assembly of hydrogel and hybrid lipid-
polymer nanoparticles using both bulk and microfluidic methods.  Chapter 2 
describes properties of the hydrogel and liposome components we have investigated, 
and discusses the nanogel characterization techniques we have used: asymmetric-
flow-field-flow-fractionation (AF4), multi-angle light scattering (MALLS), 
transmission electron microscopy (TEM), and dynamic light scattering (DLS).  
 
1.2.1. Liposome-Templated Alginate !anogels 
In Chapter 3, we present a study on bulk liposome-templated formation and 
characterization of relatively monodisperse calcium alginate nanogels.  Here, the 
cores of nanoscale liposomes are employed as reaction vessels to template the 
supramolecular assembly of calcium alginate nanogels.  For our experiments, 
liposomes composed of a formulation with a high bilayer melting temperature (Tm) 
are formed with sodium alginate encapsulated within and suspended in an aqueous 
buffer containing calcium chloride. The transmembrane diffusion of divalent calcium 
ions into the liposomal core to crosslink the encapsulated alginate chains is mediated 
by heating the sample to temperatures in the vicinity of the Tm, at which point 
transbilayer permeability is known to be increased.  Subsequently, the lipid bilayer 
covering the gel is removed by addition of a detergent.  The resulting alginate gels 




as confirmed by TEM and MALLS coupled with AF4.  We have synthesized 
nanogels of different average sizes by varying the template dimensions, and have 
demonstrated that the gel size can be further tuned after synthesis by the addition of 
monovalent salt to the solution. 
 
1.2.2. Microfluidic Directed Assembly of Alginate !anogels 
 Chapter 4 focuses on developing a microfluidic analogue of the method 
described in Chapter 3.  We attempted to use microfluidics for the self-assembly of 
liposomes and simultaneous encapsulation of sodium alginate.  The approach relies 
on diffusion between two miscible streams, and has been demonstrated previously in 
our laboratory to synthesize monodisperse liposome populations
22
.  Using modified 
formulations of the lipid and alginate, we were able to control the size distributions of 
the resultant liposome populations by changing the microfluidic mixing conditions.  
These liposomes were generally smaller compared to those synthesized by the bulk 
method in Chapter 3.  However, probably due to the smaller size, the encapsulation 
efficiency of alginate in these liposomes was found to be quite low, and consequently 
the ionic crosslinking of the liposome core was not pursued.  Although this 
microfluidic approach proved challenging to implement for larger polymers such as 
alginate, we believe it is applicable to hybrid nanoparticle systems where the 





1.2.3. Microfluidic Directed Assembly of Lipid-Hydrogel Hybrid !anoparticles 
In Chapter 5, we present a microfluidic method to direct the formation of 
lipid-hydrogel hybrid nanoparticles of engineered size using a monomeric precursor 
for hydrogels.  This method utilizes hydrodynamic focusing to precisely control the 
convective-diffusive mixing of two miscible solutions (a cholesterol/phospholipid 
formulation in isopropanol, and a monomer/crosslinker solution in aqueous buffer), 
forming nanoscale lipid vesicles with encapsulated hydrogel precursors.  These 
precursor nanoparticles are collected off-chip and UV-irradiated to crosslink the 
liquid cores into hydrogels.  Nanoparticles with low polydispersities (3 to 5%) can be 
prepared with average diameters in the 150 to 300 nm range.  These size distributions 
and structural properties are highly relevant to the targeted delivery and controlled 
release of encapsulated therapeutic agents.  This method may be extended to the 
directed self-assembly of other hybrid nanoparticle systems with engineered 
size/structure-function relationships to advance the success of soft nanoparticles for 
practical use in healthcare and life science applications. 
 
Ultimately we believe that microfluidics will offer a more automated and 
controlled nanoparticle manufacturing process, as well as allow us to explore a range 
of formation conditions more systematically and efficiently than can be accomplished 
through bulk preparation methods.  The application of microfluidics to nanoparticle 
formation has the potential to become a standardized approach to control nanoparticle 
synthesis processes and to increase our understanding of the various factors that affect 







Sodium alginate is linear unbranched bio-copolymer composed of 1,4-linked 
β-D-mannuronic (M) (Figure 2.1a) and α-L-guluronic (G) (Figure 2.1b) residues that 






) to form a 
hydrogel.  This crosslinking of adjacent polymer chains occurs via the exchange of 
monovalent sodium ions from the guluronic residues with divalent cations, thus 
forming a gel network described by the “egg-box” model.
23




















Figure 2.1.  Structure of (a) β-D-mannuronic (M) and (b) α-L-guluronic (G) residues 
in a sodium alginate polymer.   The ionic coordination of the G residues with divalent 
Ca
2+














Alginate is appealing as an in situ forming biomaterial because it is inert by 
nature, has a gentle reversible crosslinking mechanism, and its gel properties may be 
customized based on M/G ratios
24,25
.   Alginate is also referred to as a “smart” 
responsive polymer because its gel network is the result of non-covalent (i.e. 
physical) crosslinking.  It has been shown that changes in monovalent cation 
concentration and pH can cause alginate gels to swell or shrink due to ionic 
interactions with the alginate acid residues
26,27
.  Though alginate was traditionally 
used as an emulsifier or stabilizer in the food industry, recently it has been applied as 
a controlled release material in drug delivery systems,
28-30
 and as favorable matrix for 






Molecular self-assembly is ever-present in biological systems, where 
molecules spontaneously aggregate into dynamic complex structures, such as 
phospholipids assembling into cell membranes, or actin monomers organizing into 
microfilaments
34,35
.   Liposomes are well-known self-assembled models of the cell 
membrane that spontaneously form in aqueous environments by the organization of 
amphiphilic molecules into closed spherical bilayer structures, where the hydrophilic 
head groups prefer to be in contact with water and the hydrophobic tails preferred to 





















Figure 2.2.  Schematic of a liposome, with the hydrophilic head groups (blue) facing 
the water, and the hydrophobic tail groups (red) buried within the bilayer. 
 
Self-assembly is thermodynamically driven, where the system acts to 
minimize its Gibbs free energy in the process.  For this system, the liposome structure 
is favored mainly due to an increase in the entropy of water molecules due to the 
hydrophobic tails being hidden in the bilayer, which is known as the hydrophobic 
effect.  Upon formation, liposomes can encapsulate and sequester compounds from 
the aqueous environment into its interior while preserving their functionality.  This 





A well-known characteristic of lipid bilayers is their greatly increased 
permeability to small reagents at temperatures near their lipid chain melting 
temperature, Tm.  As shown in Figure 2.3, at temperatures below the Tm the bilayer is 





and rigid; at temperatures above the Tm, the lipid molecules exist in the liquid 














Figure 2.3.  Temperature effects on bilayer permeability with respect to the lipid 
chain melting temperature, Tm.  The red arrows illustrate packing discontinuities. 
 
 
In either state, lipid tail packing is continuous and the bilayer membrane is 
relatively impermeable to small molecules.  However, near the Tm, there is a 
coexistence of the two phases which causes packing discontinuities at the gel-liquid 
crystalline interfaces, and thus transmembrane permeability increases
39-42
. This 
property can be used as a trigger for facilitating diffusion of substrates into the 
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Poly(N-Isopropylacrylamide) (PNIPA) is perhaps the most widely studied 
thermally responsive “smart” polymer in controlled release and drug delivery
44,45
.  As 
shown in Figure 2.4 the precursor monomer, N-isopropylacrylamide (NIPA) mixed 
with a small amount of crosslinking monomer, N,N’-Methylene-bis-acrylamide 
(MBA) and photoinitiator diethoxyacetophenone (DEAP) can be polymerized via UV 
free radical polymerization into a hydrogel that has a characteristic low critical 













Figure 2.4.  A hydrogel precursor solution of monomer N-isopropylacrylamide 
(NIPA), crosslinking monomer N,N’-Methylene-bis-acrylamide (MBA), and photo-
initiator diethoxyacetophenone (DEAP) can be polymerized by UV irradiation into a 















At temperatures below the LCST (Figure 2.5), PNIPA is soluble in aqueous 
solutions and its hydrogels are known to swell; conversely as the temperatures above 
the LCST, the polymer chains phase separate and PNIPA hydrogels collapse.   This 
drastic transition occurs due to increasing polymer-polymer hydrophobic interactions 
and the disruption of hydrogen bonded water molecules around the amide group of 












Figure 2.5. PNIPA has an LCST of approximately 32 °C, below which the polymer is 
in a hydrated state and above which the polymer collapses.    
 
 
PNIPA has been extensively characterized and is used in many nanoparticle 
formulations as a core or shell material for controlled release studies
48
.  PNIPA is 
soluble in water at room temperature but phase separates at the physiological 
temperature (37 °C), making it an appealing material for therapeutic applications.  
Modification of the polymer such as addition of a co-monomer to the precursor 
solution prior to polymerization, or addition of other components following 
 
LCST ≈ 32 °C 
T < 32 °C 
Good Solvent Conditions 
T > 32 °C 




polymerization can alter the properties of the hydrogel and shift the LCST
49
, making 





Since its inception dating back 25 years, microfluidics has become an area of 
ever-growing interest, where the goal is to integrate processes of a chemical or 
biochemical analysis and miniaturize them onto a small microchip device, or lab-on-
a-chip.  Such a system offers many advantages over traditional bulk analyses: low 
cost of device fabrication, very low consumption of sample and reagent volumes, 
portable size, shorter sampling times, and reproducibility of mixing condition.
50
.   
 
In general, channels in microfluidic devices have height or width dimensions 
of less than 200 µm and possess unique fluidic properties owing to their micron size 
scales.  Due to dominating viscous forces at such small channel dimensions, aqueous 
flow in microchannels is typically laminar
51
, and therefore two aqueous streams 
flowing parallel to each other in the same direction have a predictable interfacial 
region where the mixing is predominantly governed by molecular diffusion (i.e. 
Brownian motion)
52-54
.  As such, small molecules and ions with a higher diffusion 
coefficient diffuse more rapidly between streams, while larger particles diffuse more 
slowly.  The ability to regulate these liquid interfaces by controlling flow rates allows 
increased control over assembly processes compared to bulk systems, which are 
affected by unpredictable turbulent flow conditions and chaotic mixing.
55















Figure 2.6.  Schematic of long-term goal for automated formations of hybrid soft 
matter nanoparticles. 
 
The ultimate goal for a microfluidic system geared towards hybrid 
nanoparticle formation, as shown in Figure 2.6, is to integrate the directed assembly, 
encapsulation, purification, and reaction steps in a single continuous-flow device. 
However, as in many microfluidic assays that involve multiple steps, integration is 
the most difficult challenge.  Therefore, our work is focused primarily on liposome 
formation and hydrogel precursor encapsulation within a microfluidic device in order 
to understand the effects on the self-assembly aspect of synthesis, which is perhaps 
the most critical step affecting the homogeneity of nanoparticle populations. 
 
 We have applied a method developed at the National Institute of Standards 














liposome populations by means of hydrodynamically focusing a stream of lipid 



















 As shown in Figure 2.7, as the miscible alcohol/lipid and aqueous buffer 
streams meet at the interface, the lipids become less soluble and eventually self-
assemble at a critical alcohol to water ratio, simultaneously encapsulating the 
surrounding aqueous solution during formation. Adjusting the degree of 
hydrodynamic focusing through the ratio of the volumetric flow rate (VFRR) of the 
buffer (Qbuffer) to that of the lipid-solvent (Qlipid), changes the microfluidic mixing 
conditions and enables the self-assembly of highly uniform liposomes with average 
diameters ranging from 40 to 100 nm.  This method is much simpler than alternate 




2.5. CHARACTERIZATIO! TECH!IQUES 
2.5.1. Asymmetric Flow Field-Flow Fractionation (AF4) 
The basic principle of AF4 is to separate species based on their diffusion 
coefficients in a flow separation channel (100-500 µm thickness depending on 




Figure 2.8.  Schematic of AF4 separation channel from Wyatt Technology.  
 
 
The upper plate of the channel is impermeable while the bottom channel plate, 
made of a porous frit material, is permeable.  The bottom plate is covered with a 




sample from exiting the separation channel. The channel has a parabolic flow profile 
of the carrier buffer solution, and simultaneously with injection of the sample, a 
crossflow is applied perpendicular to the carrier flow to focus the sample against the 
semi-permeable accumulation membrane at the bottom of the channel inlet. As the 
crossflow is gradually reduced, smaller particles reach equilibrium between diffusion 
(i.e. Brownian motion of the particle) and the force of the perpendicular crossflow 
farther above the accumulation wall, where the channel flow is faster.  Thus, 
separation occurs as smaller particles, which have larger diffusion coefficients, elute 
first with larger particles, which have slower diffusion coefficients, following later.   
 
The eluting sample can then be directly coupled to a light scattering 
instrument to obtain real-time data from each elution slice, resulting in a more 
accurate size distribution measurement.  Separation prior to light scattering lessens 
the potential of larger particles (e.g. dust, aggregates, polydispersity) to skew the 
average size data towards larger values, which is known to occur when applying 




The AF4 technique is analogous to size-exclusion chromatography (SEC), but 
with some advantages.  Unlike SEC, which uses a column loaded with a separation 
medium that may interact with and degrade the sample of interest, AF4 has no need 





2.5.2. Multi-Angle Laser Light Scattering (MALLS) 
Scattering techniques are indispensable for characterizing nanoparticle size, as 
size is considered a major factor in influencing particle efficiency and function.  
MALLS, also known as static light scattering, measures the intensity of scattered light 









Figure 2.9. Schematic of MALLS where scattered light from the incident light beam 
is measured by detectors located at fixed angles around the sample.   
 
 
For colloids, MALLS data is used to determine the radius of gyration Rg, 
which is the root mean square of mass-weighted distances of the particle’s sub-
volumes from its center of mass.  The equations for determining Rg are further 






2.5.3. Dynamic Light Scattering (DLS) 
Dynamic light scattering (DLS), also known as quasi elastic light scattering 
(QELS), probes the Brownian motion of particles in a fluid by measuring the 
fluctuating intensity of light scattered from a sample at a certain angle θ. The 
fluctuations are processed by applying an autocorrelation function ),()2( τqg vs. the 
correlation timeτ .   













τ                                    (2.1) 












q                                                       (2.2) 
where n is the refractive index of the sample solvent.   
  
 The second order intensity autocorrelation function ),()2( τqg can be converted 
to an electric field autocorrelation function ),()1( τqg using the Siegert relation: 
        
2
)1()2( ),(1),( ττ qgfqg +=                       (2.3) 
where f is an adjustable parameter that depends on the instrument geometry.  For 
dilute monodisperse spherical particles, the electric-field autocorrelation function is a 
single exponential decay that is determined by the translational diffusion coefficient 
of the particles D: 




The diffusion coefficient is then used to obtain the particle size using the Stokes-
Einstein equation: 







=                                                           (2.5) 
where kB is the Boltzmann constant, T is the absolute temperature and η  is the 
viscosity of the solvent.  DLS outputs the hydrodynamic radius Rh of the sample, 
which is the radius of the bare particle along with any solvation layer. 
 
2.5.4. Transmission Electron Microscopy (TEM) 
 Transmission Electron Microscopy (TEM) is an imaging technique that 
transmits a beam of electrons through a sample deposited on a thin film.   Electrons 
that collide with the sample are deflected while unscattered electrons pass through.  
An image is formed from the differences in transmitted electron intensity, and shows 
the structure and shape of the sample.  TEM is often done in parallel with light 
scattering for nanoparticle characterization as a qualitative check for the quantitative 
size information obtained via light scattering measurements.   
 
 Hollow core vesicles typically require negative staining prior to placing 
sample on a TEM grid in order to achieve sufficient contrast to resolve the bilayer 
membrane
57
.  Solid nanoparticles or nanogels will inherently scatter more electrons 
due to the solid composition, and thus do not require staining although it can improve 




3. LIPOSOME-TEMPLATED ALGI!ATE !A!OGELS* 
*The results presented in this chapter have been published in the following journal 
article:  Jennifer S. Hong, Wyatt N. Vreeland, Silvia H. DePaoli Lacerda, Laurie E. 
Locascio, Michael Gaitan, and Srinivasa R. Raghavan, “Liposome-templated 
Supramolecular Assembly of Responsive Alginate #anogels.” Langmuir, 24, 4092-
4096 (2008). 
3.1. I!TRODUCTIO! 
Polymer hydrogels, i.e., three-dimensional networks of polymer chains 
swollen in water, are ubiquitous in biology as well as in technology. Such hydrogels 
have long been envisioned as a means of storing an active ingredient, such as a 
therapeutic drug, flavor molecule, cosmetic ingredient, or agrochemical, and slowly 
releasing these molecules into the surrounding environment
58-60
. For example, 
hydrogels made of synthetic degradable polymers have been used in medicine as 
implantable drug delivery vehicles
61-63
. In many emerging biomedical applications, 
the size of the hydrogel is turning out to be an important control variable. For 
instance, gel particles smaller than about 200 nm can evade capture by macrophages 
in the bloodstream, and are thus more likely to remain in circulation for longer times 
compared to larger particles
36,37
. For cancer therapy also, gels ranging in size from 
about 100 to 200 nm could be particularly useful since these could penetrate into the 
vasculature of many tumors
64-67
. Thus, a need exists for small hydrogel particles in 





In this Chapter, we describe the formation of nanosized gels using lipid 
vesicles (liposomes) as a template. As is well-known, liposomes are closed structures 
formed by the self-assembly of amphiphilic lipid molecules in water, with the lipids 
organized at the liposomal shell in the form of a bilayer membrane. We employ the 
cores of nanosized liposomes as reaction vessels within which we induce the gelation 
of the biopolymer, sodium alginate under the action of divalent calcium ions. The 
gelation transforms the liposomal interior from a fluid state to a soft, elastic solid. 
Upon removal of the lipid bilayer covering the gelled core, we are left with alginate 
nanogel particles that closely match the size of the liposomal template. We 
characterize our nanogels by both optical or electron microscopy as well as light 
scattering.  A light scattering technique coupled with field-flow fractionation allows 
us to precisely compare the size distributions of the liposomes and the templated 
nanogels
68,69
. The data show that our synthesis scheme corresponds to a true 
templating reaction, and that our procedure can be extended to preparing nanogels of 
different sizes and chemistries. Moreover, these alginate nanogels can be 
subsequently reconstituted as stable dispersions in water or buffer solutions. 
 
Several earlier studies have reported gel synthesis using liposomes as 
templates
8,10,14,15,70,71
, although in most of these cases the focus was on relatively 
large gel particles. Only one group has systematically studied the synthesis of 
nanosized gels via liposomal templates.  Those gels were based on the synthetic 
polymer, poly(N-isopropylacrylamide) (PNIPA)
13,72,73
. Our interest in this study is on 








To improve the templating process, our approach is to use a trigger 
mechanism to initiate crosslinking within our liposomal cores. We exploit a well-
known property of lipid bilayers, which is that the bilayers become more permeable 
close to their bilayer melting temperature Tm
39,40,42,74
. The increased permeability 
arises because near Tm, the bilayer exhibits a co-existence of “gel” domains (in which 
the lipid tails are elongated and rigid) and liquid crystalline domains (where the lipid 
tails are fluid). Between these domains, there are grain boundaries, which causes the 
formation of pores in the membrane, in turn leading to an increase in transmembrane 
permeability. Here, we use lipids that have a Tm above room temperature to form our 
liposomes, and we encapsulate sodium alginate in these liposomes (Figure 3.1). 
Thereafter, we introduce Ca
2+
 ions into the solution, and we raise the temperature to 
the Tm.  Thereby, we facilitate the diffusion of Ca
2+
 ions into the liposomal core, 
where the ions crosslink alginate chains at junction zones (this is the well-known 
“egg-box” mechanism). We have used alginate in our studies because it is appealing 











Figure 3.1.  Schematic of alginate nanogel synthesis using liposomal templates. 
Liposomes encapsulating sodium alginate are placed in a 10 mmol/L CaCl2 solution 
and exposed to temperatures near the Tm of the lipid. The increased transmembrane 
permeability allows Ca
2+
 to diffuse into the liposomes and ionically crosslink the 




The ability to gel the cores of liposomes has applications beyond drug 
delivery. Specifically, it is worth noting that eukaryotic cells can generally be 
considered as gels enclosed by a bilayer membrane, where the gel is formed by the 
polymerization of cytoskeletal proteins such as actin, filamin, and tubulin. Thus, a 
liposome with a gelled core might be a better model for a biological cell compared to 
a buffer filled liposome
75
. Moreover, a gelled liposome could find applications as a 
container for single molecule fluorescence studies, e.g., in localizing a single DNA or 
protein molecule within the interior. These types of fundamental studies will be the 





3.2. EXPERIME!TAL SECTIO! 
Materials. The lipid, 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC, > 99% 
purity) and cholesterol (> 98% purity) were purchased from Avanti Polar Lipids 
(Alabaster, AL). Other amphiphiles and chemicals were purchased from  Sigma-
Aldrich (St. Louis, MO), including the lipid, dicetyl phosphate (DCP), the detergent, 
octyl-ß-glucopyranoside (OBG), sodium azide (NaN3), and 
ethylenediaminetetraacetic acid (EDTA). The alginate biopolymer was also obtained 
from Sigma-Aldrich and it was a low-viscosity sodium alginic acid, composed 
primarily of 1-4 β-D-mannuronic acid residues. The molecular weight of the polymer 
was determined to be around 145 kDa by light scattering (Zimm plot). Salts NaCl and 
CaCl2 were purchased from Fisher Scientific (Pittsburgh, PA). The buffer ingredients, 
tris(hydroxymethyl)aminomethane (Tris) from Amresco (Solon, OH) and N-
tris(hydroxymethyl)methyl-3-amino-propanesulfonic acid (TAPS) from Midwest 
Scientific (Valley Park, MO) were used to prepare Tris-TAPS-NaCl buffer (at pH 
8.0) by combining 50 mM of Tris and TAPS and 15 mM NaCl. A Tris-TAPS-CaCl2 
buffer was also prepared, with the same Tris and TAPS concentrations and combined 
with 10 mM of CaCl2. 3 mM NaN3 was added to all buffer solutions to prevent 
bacterial contamination. 
 
Liposome Preparation. A lipid formulation consisting of DPPC:cholesterol:DCP 
(7:2:1 molar ratio) was used to prepare liposomes by the solvent injection method
76,77
. 
This method involved dissolving 5 µmol of the lipid formulation in chloroform and 




placed in a vacuum dessicator overnight to completely remove any residual solvent. 
The dried lipid film was resolubilized in 50 µL dry isopropyl alcohol (IPA) and was 
injected into 1 mL of Tris-TAPS-NaCl buffer while vortexing, which yielded control 
liposomes at a concentration of 5 mM. To prepare liposomes containing the alginate 
in their cores, the alginate was added to the buffer solution prior to lipid injection. 
Details on alginate nanogel preparation are given in the Results section.  Details on 
alginate nanogel preparation are given in the Results section.   
 
Light Scattering and Asymmetric Flow Field-Flow Fractionation (AF4).  An 
Eclipse Asymmetric Flow Field-Flow Fractionation (AF4) instrument integrated with 
a multi-angle laser light scattering (MALLS) instrument was used for size separation 
and characterization of the liposomes and nanogels (model DAWN EOS, Wyatt 
Technology, Santa Barbara, CA).  A 250 µm spacer was used to define the flow 
channel thickness, and a MWCO regenerated cellulose membrane with a 10 kDa 
cutoff was used for the cross-flow partition.  Tris-TAPS-NaCl buffer was used as the 
carrier solution in all AF4 runs, and the flow was controlled using vendor-supplied 
software (Eclipse 2, Wyatt Technology). For the control liposomes, 10 µL of the 
solution was injected at a flow rate of 0.2 µL/min, and the separation was conducted 
with a 1 mL/min channel flow with a crossflow that was linearly reduced from 0.8 
mL/min to 0 mL/min over a period of 70 min. For the templated nanogels, the same 
conditions were used, except with a 30 µL sample injection volume and 60 min 
elution time. MALLS data were collected simultaneously at 10 scattering angles on 





The raw MALLS data (intensity vs. scattering angle) was analyzed as follows 
using the instrument software. From the Rayleigh-Debye-Gans Theory, the light 
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θ  (3.2) 
Here, R(θ) is the excess Rayleigh ratio, K* is a physical constant, c is the 
concentration, M is the molecular weight, A2 is the second virial coefficient, n0 is the 
index of refraction, λ0 is the wavelength of the incident laser beam, and Rg is the 
radius of gyration.  For dilute systems, the second virial coefficient A2 can be 















will be a straight line, and from the slope, the radius of gyration gR  can be obtained. 
The Rg for each eluting slice can thus be obtained, and these values can be combined 




Transmission Electron Microscopy (TEM).  TEM of alginate nanogels was 
performed on a Philips EM 400T microscope operating at 120 kV equipped with a 




dropping diluted dispersions of the nanogels onto 600-mesh carbon-coated copper 
grids, following which the grids were immediately freeze-dried (lyophilized).  
 
Optical Microscopy.  Optical micrographs of larger liposomes and alginate gel 
particles were obtained using a Carl Zeiss Axiovert 200 inverted microscope with a 
40x differential interference contrast (DIC) objective.  
 
3.3. RESULTS A!D DISCUSSIO! 
3.3.1. !anogel Synthesis  
The template liposomes used here are formed from a mixture of 
DPPC:cholesterol:DCP in a molar ratio of 7:2:1. The major component, DPPC, is a 
zwitterionic lipid having a Tm of ≈ 42 °C, which means the liposome bilayers are in 
their gel state at room temperature
42
. We incorporated cholesterol in our lipid 
formulation because low amounts of cholesterol further enhance membrane 
permeability near Tm (see below)
40,42
. DCP is an anionic lipid that gives a net negative 





To prepare liposomes containing alginate, we first added 1 % w/v sodium 
alginate to Tris-TAPS-NaCl buffer and then injected the lipid formulation in IPA into 
this buffer solution. This procedure results in liposomes containing some sodium 




the liposomes to five freeze-thaw cycles with liquid nitrogen and hot tap water. 
Freeze-thaw cycles are useful for enhancing encapsulation of solutes like alginate, 
since freezing tends to disrupt membrane bilayers, which may cause the solute to 
enter the liposome upon thawing and membrane reformation
79
. Unencapsulated 
alginate was thereafter removed via three centrifugation/buffer rinses, each at 13,200 
rpm for 10 min, with resuspension in 1 mL Tris-TAPS-NaCl buffer. The last 
resuspension was done with 1 mL of Tris-TAPS-CaCl2 buffer to initiate gelling of the 
sodium alginate chains in the liposomes via the divalent Ca
2+
 cations.   
 
As discussed in the Introduction, we exploited the increased permeability of 
bilayers near their Tm to facilitate entry of Ca
2+
 into the liposome core
39,40,42,74
. To 
expose the sample to a temperature cycle across Tm, we placed alginate-containing 
liposomes in a heated water bath (60 °C) followed by an ice bath (0 °C), both under 
continuous stirring. The rate of temperature change was measured by a digital 
thermometer and was approximately 1 °C/s in both cases. Samples were exposed to 
10 such temperature cycles across the Tm of DPPC. The net effect is that Ca
2+
 ions 
diffuse increasingly through the bilayer and crosslink the alginate chains, as shown in 
Figure 1. We are thus able to accomplish alginate gelation in the liposome cores using 
a low Ca
2+
 concentration gradient. The lipid bilayer still covers the gel particles, and 
so what we have at this stage are nanosized lipobeads. The lipobeads were rinsed 
three times by centrifugation  (13,200 rpm for 10 min) using 1 mL of Tris-TAPS-
NaCl that also contained 2 mmol/L of the Ca
2+





Next, we converted the lipobeads to nanogels. The lipid bilayers around the 
lipobeads were removed by adding 30 mmol/L of OBG. OBG is a single-tailed 
detergent that is known to disrupt lipid bilayers because the detergent has a very 
different (cone-shaped) molecular geometry compared to conventional lipids (which 
are cylinder-shaped). The OBG treatment results in a stable dispersion of calcium 
alginate nanogels. The nanogels were rinsed by centrifugation (13,200 rpm for 10 
min) and resuspended in 0.3 mL Tris-TAPS-NaCl buffer. Nanogel dispersions in 
buffer remained stable over the period of observation (several weeks). For 
comparison with the nanogels, we also ran two controls through the same above 
procedure, viz. empty DPPC:cholesterol:DCP liposomes and the same liposomes 
encapsulating ungelled alginate (in the latter case, the Ca
2+










































Figure 3.2.  Data from light scattering for the template liposomes and alginate 
nanogels, following AF4 fractionation. The radius of gyration Rg is shown in (a) 
while the scattering intensity (normalized Rayleigh ratio) at 90° is shown in (b).    
 
3.3.2. !anogel Characterization by Light Scattering.   
Figure 3.2 shows real-time light-scattering data for the template liposomes 
and for the alginate nanogels, following size-fractionation by AF4. As described in 
the Experimental Section, the light-scattering data for each AF4 elution slice are 
analyzed to obtain the corresponding radius of gyration Rg. Figure 3.2a plots the Rg as 
a function of elution volume while Figure 3.2b shows corresponding data for the 




























































scatter strongly, and their Rg ranges from 55 nm to 112 nm. The nanogels prepared 
from these liposomes have a more narrow range of 65 nm to 85 nm for their Rg. Thus 
the nanogel sizes fall within those of the template liposome. Note that the peak 
scattered intensity in Figure 3.2b from the nanogels is about 4-fold weaker than that 
from the template liposomes, which means that the number density of nanogels is low 


















Figure 3.3. Size distributions of the template liposomes (a) and the alginate nanogels 





















































































































The data in Figure 3.2 are converted into size distributions in Figure 3.3 for 
both the template liposomes and the alginate nanogels. The template liposomes 
(Figure 3.3a) have a size distribution peaked around a radius of about 63 nm followed 
by a long tail. The nanogels (Figure 3.3b) show a slightly wider peak centered around 
a radius of ca. 75 nm, but the long tail is absent. Thus, on average, the nanogels are 
slightly larger than the template liposomes, due in part to their tendency to swell in 
solution (see below). On the whole, however, the sizes of the two structures are quite 
comparable. In other words, the nanogels do correspond in size to their liposome 
molds, i.e., a true templating has been achieved. Note that the peak number density of 
the template liposomes is at least two orders of magnitude greater than that of the 
alginate nanogels. This is consistent with Figure 3.2b and implies that the yield of 
nanogels is quite low. We attribute the low yield to the low encapsulation efficiency 
of alginate in the liposomes. The encapsulation efficiency of polymers in liposomes is 
generally quite low (< 10 %), especially for large polymer coil sizes
80
.      
 
 We further confirmed nanogel formation by comparing the nanogel sample to 
the two controls (empty liposomes; liposomes with ungelled alginate), following 
OBG detergent treatment. Figure 3.4 plots the scattered intensity (normalized excess 
Rayleigh ratio at 90°) for each of these samples as they elute from the AF4 device. 
The OBG should disrupt the liposomes in both controls and convert them into smaller 
micelles, which in turn should get removed by the centrifugation/buffer rinses. Thus, 
we expect to see minimal scattering from the control samples. On the other hand, the 




should still scatter strongly. This is indeed what we find in Figure 3.4: the scattering 
from the nanogels is quite high, whereas the scattering from each of the two controls 
is negligible. Figure 3.4 thus confirms that we have indeed formed nanogel particles 









Figure 3.4.  Light scattering intensities (normalized Rayleigh ratios) at 90° for 
samples passed through the AF4 setup following OBG detergent treatement. Data are 
shown for the template liposomes (blue), liposomes containing ungelled alginate 
(green), and alginate nanogels (red). Only the nanogels show a significant scattering 
intensity. 
       
3.3.3. !anogel Characterization by TEM   
In addition to the indirect characterization by light scattering described above, 
we have also obtained direct images of nanogels using TEM. To obtain these images, 
drops of the rinsed nanogel dispersion were placed on TEM grids, which were then 
freeze-dried. No further contrast enhancement or staining was done. TEM images of 
























































distinct spherical structures, well-separated from one another. The spheres have radii 
around 25-50 nm, which are smaller than the values measured by light scattering. 
However, the TEM sizes correspond to dried nanogels whereas the light scattering 
was done on nanogels in solution. Indeed, alginate nanogels in aqueous solution are 
known to swell up to several times their dehydrated size
27,81
. We also performed TEM 
studies on a control sample of freeze-dried template liposomes, but no structures 
could be observed (results not shown). This is consistent with the notion that 
liposomes are fragile, self-assembled structures that get disrupted during the freeze-









Figure 3.5.  Typical TEM image of freeze-dried alginate nanogels.  The nanogels are 
relatively monodisperse and exhibit the shape and size of their liposome templates. 
 
3.3.4. !anogel Response to Salt (!aCl) 
The above data confirm the successful synthesis of alginate nanogels using 
liposomes as templates. But do these nanogels show the same responsive properties 




effect of adding NaCl to the nanogel dispersions. If Na
+
 ions from the bulk solution 
were to exchange with the Ca
2+
 crosslinks in the alginate gel, the net degree of 
crosslinking of the gel would be lowered, and consequently the gel would swell 
more
27,81
. We have therefore monitored changes in the nanogel radius at increasing 
NaCl concentrations. The control sample of nanogels in Tris-TAPS-NaCl buffer 
corresponds to an overall NaCl concentration of 115 mmol/L. Additional NaCl was 
added to this sample to bring the Na
+
 concentration to 250 mmol/L, and the sample 
was incubated overnight and then analyzed by light scattering. The same procedure 
was then repeated for an Na
+
 concentration of 400 mmol/L. Figure 3.6 shows results 
for the radius of gyration Rg of the nanogels estimated from the light scattering data. 
As expected, we find a significant increase in nanogel radius with increasing NaCl 
concentration. These results demonstrate that nanogel properties can indeed be 










Figure 3.6. Sizes of alginate nanogels at different concentrations of NaCl. The data 






































Figure 3.7.  Optical (DIC) micrographs of alginate gels templated by larger (micron-
sized) vesicles. (a) Before OBG treatment (i.e., with lipid shell intact), and (b) after 
OBG treatment (i.e., bare gel particles).     
 
All the results thus far have been for nanogels templated from relatively small 
liposomes (~ 100 nm in radius). A final question we address is  whether we can 
control the size of the gels by varying the size of the template liposomes. By using a 
lipid formulation of DPPC:DCP (9:1 molar ratio), we can obtain liposomes of ca. 400 
nm to 500 nm in radius using the solvent injection method. Note that, at these larger 
sizes, the liposomes could well be a combination of unilamellar and multilamellar 
structures. Nevertheless, we have been able to encapsulate alginate in these liposome 
cores, and we have subsequently crosslinked the alginate chains by exposure to a Ca
2+
 








can be obtained directly from optical (DIC) microscopy. Figure 3.7a shows a 
micrograph of the gel particles with intact lipid bilayers (before OBG treatment). We 
can resolve a large number of distinct spherical structures in this image. Figure 3.7b 
shows the same sample after treatment with 30 mmol/L OBG. Here again, we find 
distinct gel particles with approximately the same size as in Figure 3.7a, although the 
number density of such particles is significantly lower. For comparison, we also 
obtained DIC micrographs of a control sample of liposomes alone – in this case, upon 
exposure to OBG, the liposomes were destroyed, and no structures could be resolved 
by DIC. Light scattering also confirmed that the average radius of the gel particles 
was around 500 nm; i.e., comparable to that of the template liposomes. The data 
suggest that our templating strategy can be generalized to gels over a range of sizes.    
 
3.4. CO!CLUSIO!S 
We have used liposomes to template relatively monodisperse populations of 
alginate nanogels. The solvent-injection method was used to form the liposomes and 
simultaneously encapsulate sodium alginate in the liposome cores. Alginate gelation 
in the liposome cores  was accomplished using a low Ca
2+
 concentration gradient by 
exploiting the increased transbilayer permeability near Tm. The lipid coating around 
the nanogels was then removed by the addition of OBG detergent. Light scattering 
and TEM confirmed the formation of nanogels. Experiments with two different 
liposome sizes showed that the gel particles conform to the sizes of the templates. 
The nanogels described here could be useful for biomolecule encapsulation either in 








 Following the results of the bulk experiments to template alginate nanogels in 
Chapter 3, we sought to improve size control of the nanogels by replacing the bulk 
solvent-injection method with the microfluidic approach described in Section 2.4. As 
mentioned earlier, the microfluidic approach gives better control over liposome sizes 
and encapsulation
55
. In this approach, a lipid/solvent stream is hydrodynamically 
focused by an aqueous buffer solution that is miscible with the solvent. The 
liposomes form at the interface between the two streams, where the solubility of lipid 
decreases as the aqueous buffer diffuses into the solvent containing the lipid.  The 
liposome size can be controlled by varying the volumetric flow-rate-ratio (VFRR) of 
the aqueous buffer outer streams to the central focused lipid-solvent stream
82
.   
 
The adaptation of this method for the assembly of alginate nanogels is shown 
in Figure 4.1. It involves on-chip formation of liposomes and simultaneous 
encapsulation of sodium alginate.  After the samples are collected at the microchannel 
outlet, the ionic crosslinking of the liposome cores into nanogels can then be 
conducted off-chip. Note that, while the ultimate goal would be the complete on-chip 














Figure 4.1.  Microfluidic approach to the directed assembly of alginate nanogels.  
On-chip steps of liposome self-assembly and simultaneous encapsulation of sodium 
alginate are followed by off-chip purification, temperature-triggered liposome 
permeabilization, ionic crosslinking via Ca
2+
, and subsequent lipid removal. 
 
 
The studies in this Chapter primarily concern the on-chip part, i.e., formation 
of liposomes with encapsulated sodium alginate. We encountered some challenges in 
these studies, including phase separation at the microfluidic mixing interface due to 
poor polymer-solvent interactions between the alginate-buffer streams and the 
focused lipid-solvent stream. Ultimately we were able to solve some of these issues 
and produce liposomes in the microfluidic device, but the encapsulation of sodium 
alginate in these liposomes was quite low. The off-chip steps were not carried out due 
to the low encapsulation of the hydrogel precursor molecules, and we concluded that 
the encapsulation would be improved with an alginate oligosaccharide or a 
monomeric hydrogel precursor, both of which would diffuse quickly in the 
microfluidic mixing region and also interact less with the solvent, and thus increase 




4.2. EXPERIME!TAL SECTIO! 
Materials. Alginic acid sodium salts (20 cP and 250 cP), fluoresceinamine isomer I 
(FA), N-Hydroxysulfosuccinimide sodium salt (NHS), N-(3-Dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC), dihexadecyl phosphate (DCP), and 
sodium azide (NaN3) were obtained from Sigma Aldrich.  Buffer components Tris 
free base was purchased from Amresco, and N-tris(hydroxymethyl)methyl-3-amino-
propanesulfonic acid (TAPS) was obtained from Midwest Scientific.  Sterile luer-lock 
plastic syringes (1 mL and 3 mL) were obtained from Daigger. Lipophilic tracer 1,1'-
dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate (DiD) was obtained 
from Invitrogen (structure in Figure 4.2).  
 
                           
 
 
Figure 4.2. Chemical structure of DiD intercalating membrane dye (Invitrogen). 
 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and cholesterol were 
obtained from Avanti Polar Lipids. Tris-TAPS-NaCl buffer (pH 8.0) was prepared by 
combining 50 mM Tris, 50 mM TAPS, and 15 mM NaCl. 3 mM NaN3 was added to 
all buffer solutions to prevent bacterial growth.  This buffer was used for all sample 
preparation and characterization techniques. The primary lipid formulation consisted 





Microfluidic Device Fabrication. Microfluidic devices were fabricated in silicon 
and bonded to borosilicate glass using standard microfabrication processes.  A thin 
film of positive tone photoresist was spin-coated onto the front side of a double side 
polished silicon substrate wafer with a thickness of ≈ 290 µm.  Networks of fluidic 
channels with widths of ≈ 21 µm were patterned in the photoresist using contact 
photolithography.  Device patterns were transferred into the substrate using Bosch 
Process deep reactive ion etching to a depth of ≈ 39 µm.   
 
  
Figure 4.3.  Schematic of microfluidic device design with an enlarged illustration of 
the hydrodynamic focusing device.  With the small channel dimensions required for 
microfluidic experiments, multiple devices of different channel widths can be 





Microfluidic Liposome Formation. Liposomes encapsulating sodium alginate were 
self-assembled with controlled microfluidic mixing by hydrodynamic focusing
82
.  The 
lipid film was redissolved in dry 0.1 µm-filtered solvent to obtain a 6.25 mM 
solution.  The lipid solution and the alginate in Tris-TAPS-NaCl solution were each 
loaded in a plastic 3 mL luer lock syringe and were connected to the device access 
nanoports, as shown in Figure 4.3.  Syringe pumps were used to control the flow of 
lipid-solvent solution into the center channel and alginate in buffer into the side 
channels to hydrodynamically focus the central lipid-solvent stream.   
 
Microfluidic synthesis was monitored with an inverted optical microscope 
used in epifluorescence mode. Imaging was done through the cover wafer with plan 
apochromat air immersion objectives of 20x and 40×, and numerical aperture 0.95.  A 
metal halide arc lamp was used with a 625 to 655 nm band pass filter for fluorescence 
excitation of DiD, and fluorescence emission was isolated with a 660 nm dichroic 
mirror and refined with a 665 to 715 nm band pass filter.  For detection of the FA 
dye, a 450 to 490 nm band pass filter was used, and the fluorescence emission was 
isolated with a 515 to 565 nm band pass filter.  These dyes were selected such that the 
emission spectrum of the FA dye would be isolated from the excitation range of the 
DiD.  Images were acquired with an electron multiplying device camera. 
 
AF4-MALLS. The Eclipse AF4 / Dawn EOS MALLS used in Chapter 3 was also 
employed here.  20 µL of each sample collected from the microfluidic formation were 








channel flow and a 2.0 mL min
-1 
to 0.0 mL min
-1
 linearly decreasing crossflow 
gradient over 75 min. MALLS data was collected on eluting samples at 10 angles 
simultaneously.  A coated sphere model
83
 was applied to the data using an estimated 
bilayer thickness of 5 nm to determine geometric radii distributions of the liposomes. 
 
4.3. RESULTS A!D DISCUSSIO! 
4.3.1. Fluorescent Labeling of Sodium Alginate 
To visually observe the microfluidic focusing interface, sodium alginate was 
labeled by adapting a previously reported method
84
.  1.78 % w/v aqueous solutions of 
250 cP and 20 cP sodium alginate were incubated with 9 mM EDC and 9 mM NHS 
for 2.5 h, and 1 mM FA was added to the solution and was incubated for another 
20 h.  The sample was dialyzed against Tris-TAPS-NaCl for 24 h, with three buffer 
exchanges.  The resultant fluorescently-labeled 20 cP and 250 cP alginate samples are 
shown in Figure 4.4a and Figure 4.4b, respectively.     
  













Figure 4.4. Fluorescence micrographs of 1.78% w/v of (a) 20cP and (b) 250 cP 





4.3.2. Microfluidic Formation of Alginate-Encapsulating Liposomes 
Initially, we dissolved the lipid in IPA and used a solution of 1% w/v of the 
250 cP sodium alginate in aqueous buffer. At the continuous interface between the 
center lipid-IPA and sheath alginate-buffer streams in the microfluidic device, 
unfavorable polymer-solvent interactions occurred, which had a pronounced negative 
effect on the formation of liposomes.  Phase separation was observed immediately 
after the onset of flow (Figure 4.5a) and became progressively worse after 15 min 
(Figure 4.5b).  Shortly thereafter this phase separation completely obstructed fluid 
flow in the microfluidic channel at the hydrodynamic focusing interface, preventing 
the collection of sample. 
 














Figure 4.5. Chemical insolubility between the 250 cP sodium alginate polymer and 







To improve the chemical compatibility between the mixing streams, we made 
modifications to the lipid and alginate formulations.  In the bulk solvent-injection 
method (Chapter 3), the lipid is dissolved in a much smaller volume of IPA and is 
injected once into a much larger volume of the buffer solution – thus any phase 
separation between the two solutions was transient.  The microfluidic method requires 
a continuous interface between the solvent and aqueous streams, with a higher 
surface-to-volume exposure of the polymer to the solvent, which magnified the 
chemical incompatibilities.  We experimented with various solvent concentrations, 
lipid concentrations and alginate concentrations, as well as with the lower viscosity 
(20 cP) sodium alginate polymer, and were finally able to resolve working 






Figure 4.6. Chemical structures of isopropanol (IPA) and ethanol (EtOH).  EtOH is 
slight less hydrophobic than IPA, which cause less phase separation of the alginate a 
the hydrodynamic focusing interface of the microfluidic channel. 
 
The working lipid formulation was a 6.25 mM concentration of lipid in 3.2 
mL of a solvent mixture consisting of 75% ethanol (EtOH): 25% IPA by volume.  
The lipid was dissolved in 0.8 mL of IPA first, and then three 0.8 mL aliquots of 
EtOH were added.  EtOH was chosen due to its similarity to IPA, but its slightly more 
hydrophilic chemical structure due to one less methylene group than IPA (Figure 4.6) 





improved the solvent compatibility with the sodium alginate compared to the initial 
100% IPA solvent.  The lipid solubility was maintained in the 75% EtOH: 25% IPA 
mixture, while decreasing the adverse interactions with sodium alginate during the 
microfluidic-directed formation.  The working sodium alginate formulation was a 
0.25% w/v 20 cP sodium alginate solution in Tris-TAPS-NaCl.  A decrease in 
concentration and a move to a lower viscosity alginate helped mitigate the poor 
polymer-solvent interactions at the mixing interface. 
 













Figure 4.7.  Microfluidic formation of alginate-containing liposomes. The images 
with dual channel acquisition show the DiD-labeled lipid (red) and FA-labeled 
alginate (green).  Over the course of the experiment, interfacial build-up due to phase 
separation of alginate in the hydrodynamic focusing region increased near the glass 
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Fluorescence micrographs of the microfluidic directed assembly of liposomes 
based on this formulation over time are shown in Figure 4.7. Although phase 
separation increased at the mixing interface over the duration of the experimental run, 
the microchannel was never completely obstructed and we were able to collect 
liposomes at volumetric flow-rate-ratios (VFRRs) of 6:1, 9:1, and 12:1. 
 
4.3.3. Size Characterization with AF4-MALLS 
 Liposomes collected from the microfluidic device outlet at each VFRR were 
characterized by AF4-MALLS, and their size distributions are shown in Figure 4.8a.  
Each data point represents a MALLS measurement made on an AF4 size-fractionated 
component of the entire liposome sample
68
.  Figure 4.8b shows a plot of the average 
radius and the standard variability of each sample as calculated by one standard 
deviation from the mean.  Average radii were weighted by the particle densities from 
Figure 4.8a to give a more representative average value for each population.  The data 
indicate that we produced relatively monodisperse and discrete nanoscale liposome 
populations. The expected trends of smaller liposome size and narrower size 
distribution with increasing VFRR are seen in Figure 4.8b
22
.  Figure 4.8b displays a 
nearly linear correlation between average radius and VFRR.  The microfluidic 
method thus leads to improved size control of alginate-containing liposomes over 
those formed by the bulk method in Chapter 3, while also having the advantage of 
fewer processing steps.  The sizes of these liposomes are within a relevant range for 
therapeutic applications, and in general are smaller than the alginate nanogels 






                    
  




































Figure 4.8.  Size characterization of liposomes encapsulating sodium alginate.  (a) 
Size distributions of liposomes with 20 cP sodium alginate, synthesized at varying 
VFRRs and (b) the average radius and variance of each of the above distributions.  
Both sets of data show the expected trend of decreasing size and narrowing size 




4.3.4. Encapsulation of Sodium Alginate 
 Dual-channel fluorescence micrographs of a 1:50 diluted sample of alginate-
containing liposomes following microfluidic formation at a 6:1 VFRR are shown in 
Figure 4.9.  An overlay of the DiD-labeled liposomes (red) and the FA-labeled 
alginate (green) was used to qualitatively confirm encapsulation before proceeding.  
The incidence of liposomes with overlapped fluorescence of alginate molecules was 
extremely low .  In the case of the 9:1 and 12:1 VFRR samples, the encapsulation was  
practically negligible (data not shown). This is probably because the liposomes 
become smaller as the VFRR increases (Figure 4.8), making the encapsulation of the 
alginate, a relatively large macromolecule
85












Figure 4.9.  Dual-channel fluorescence micrographs of liposomes encapsulating 
20 cP sodium alginate, formed at a VFRR of 6:1.  The red and (a) green particles 
indicate empty liposomes and unencapsulated alginate, respectively.  The (b) yellow 
particle is a result of overlapping red and green fluorescence, which is an indication 
of a liposome encapsulating sodium alginate.  The low incidence of yellow particles 
indicates that the encapsulation efficiency was extremely low. 






 Our results suggest that the microfluidic method may be better suited for 
forming liposomes that encapsulate lower molecular weight precursors and thereafter 
for templating the assembly of nanogels from those precursors.  Further modifications 
to our current approach would likely aid in increasing the encapsulation efficiency of 
sodium alginate.  One such modification might be to cleave the alginate into smaller 
oligosaccharides via enzymatic digestion.  Smaller oligosaccharides would likely be 
more compatible within the microfludic mixing interface, which would allow us to 
use a more concentrated alginate formulation and thus increase the potential for 
encapsulation within the liposomes.   
 
4.4. CO!CLUSIO!S  
 We have explored a microfluidic approach for the assembly of liposomes 
encapsulating sodium alginate, which is a necessary step towards the goal of forming 
alginate nanogels using microfluidics.  Formulations of lipid and sodium alginate 
solutions were modified to enable assembly of nanoscale liposomes containing 
alginate by microfluidic hydrodynamic focusing. The average size of the resultant 
liposomes could be altered by changing the flow rates of the lipid and alginate 
streams.  The extent of encapsulation of the alginate proved to be quite low, which 
was attributed to the large size of the polymer relative to the sizes of the liposomes.  
We believe our method would be more suitable for the templating of low molecular 
weight precursors, such as oligomers or monomers, and this will be investigated 




5.  MICROFLUIDIC DIRECTED ASSEMBLY OF LIPID-
HYDROGEL HYBRID !A!OPARTICLES* 
*The results in this chapter are currently in preparation for a manuscript submission 
to Langmuir (2009). 
5.1. I!TRODUCTIO! 
Soft nanoparticles such as nanoscale lipid vesicles, hydrogel nanoparticles, 
and hybrids of the two have many important applications in healthcare and the life 
sciences
8,86










.  Particular interest has grown in these nanoparticles as potential 
carriers for the targeted delivery and controlled release of therapeutic agents for 
diagnostic and treatment purposes
5,11,18,21,90
.  Although many types of these 
nanoparticles have been developed, few have advanced to clinical use because of a 
lack of consistent toxicology data, which in turn arises partly because nanoparticle 
preparation techniques yield erratic results across laboratories
91
.     
 
Nanoparticles are largely synthesized using bulk techniques.  Phospholipid-
based nanoparticles are typically synthesized using evaporation-rehydration or 
solvent-injection methods, while polymeric nanoparticles are traditionally prepared 
using emulsion-based or solvent-evaporation methods
92-94
.  The technical limitations 
associated with bulk methods for synthesizing soft matter nanoparticles constitute a 




limitations include nanoparticle size distributions that are polydisperse, irreproducible 
from batch to batch, and strongly dependent on chemical formulation
18,95
.  A root 
cause of these problems is the disparity between macroscopic control over the 
reaction of nanoparticle precursor solutions and the microscopic fluid environment 
which determines the formation of nanoparticles.  These limitations often necessitate 
the use of post-processing techniques such as high frequency sonication, freeze-thaw 
cycling, or membrane-extrusion to homogenize nanoparticle size and composition, 
which  can decrease yield, increase assembly time, and can be incompatible with 
biological applications
15
.   
 
To address these limitations, a variety of microfluidic methods have recently 
been developed to synthesize soft nanoparticles with improved control over size 
distribution, as size has been determined to be a critical factor in influencing 
nanoparticle efficacy or toxicity for a particular application
91,96
.  One such method is 
the use of microfluidic hydrodynamic focusing
52
 to precisely control the convective-
diffusive mixing of miscible liquids at the nanometer length scales and microsecond 
time scales that determine the formation of nanoparticles.  This approach has been 
used to direct the self-assembly of lipid molecules into nanoscale lipid vesicles of 
controlled size in a continuous and reproducible manner
55
, obviating the need for 
post-processing to homogenize nanoparticle size.  Similar microfluidic approaches 







Beyond these single-material lipid or polymer nanoparticle systems that have 
been synthesized using microfluidic devices, relatively few microfluidic methods for 
the precisely controlled synthesis of multiple-material hybrid nanoparticle systems 
have been demonstrated even though there are many known important applications 
for them.  In particular, lipid-hydrogel hybrid nanoparticles, also known as lipobeads, 
combine many of the advantageous material properties of the individual constituents 
for therapeutic applications
8,12
.  The hydrogel interior improves both the mechanical 
stability of hybrid lipid-hydrogel nanoparticles and the controlled release of 
encapsulated therapeutic agents, while the many useful surface properties of the 
exterior lipid vesicle are retained for both stealth capability and targeted 
delivery
13,16,70,93,98,99
.  This potential therapeutic utility motivates the development of 
advanced microfluidic methods to control the synthesis of these more structurally 
complex soft matter nanostructures. 
 
In this Chapter, we present a microfluidic approach to the directed assembly 
of monodisperse lipid-hydrogel hybrid nanoparticles of controlled size.  We selected 
poly(N-isopropylacrylamide) (PNIPA) as our model polymer, as it is one of the most 
widely studied thermo-responsive polymers for therapeutic applications, and also 
because it has been used recently for the bulk formation of lipobeads
14,44,72,73
. As 
shown in Figure 5.1, our approach utilizes microfluidic hydrodynamic focusing to 
control the convective-diffusive mixing of two miscible liquids
82
 that separately 
contain the precursors to our hybrid nanoparticles. One solution contains a mixture of 




Figure 5.1a. The outer sheath flow consists of an aqueous solution of N-isopropyl-
acrylamide (NIPA), crosslinker, and free-radical initiator, in phosphate-buffered 
saline (PBS).  
    
 









   















Figure 5.1.  Schematic of the on-chip microfluidic-directed assembly and off-chip 
polymerization of lipid-PNIPA hydrogel nanoparticles.  (a) A solution of lipid and 
lipophilic tracer DiD (red) dissolved in IPA was hydrodynamically focused by a 
solution of the hydrogel precursor in buffer.  Microfluidic mixing was used to direct 
the formation of nanoscale lipid vesicles with encapsulated gel precursors, and the 
sample was collected (b) at the device outlet. (c) The extravesicular gel precursor 
material was removed by gel filtration, and the particles were resuspended in buffer.  
(d) Subsequent UV irradiation initiated the free-radical polymerization of the 










Using this approach, we can direct the assembly of liposomes at the interface 
between the two streams, and these liposomes will encapsulate the contents of the 
aqueous solution, i.e., the hydrogel precursors. Moreover, by varying the volumetric 
flow-rate-ratio (VFRR) of the aqueous outer streams to the central lipid-IPA stream, 
the convective-diffusive mixing conditions at the interface are altered, and thereby the 
size of the liposomes can be controlled
82
. The liposomes at the outlet of the 
microfluidic chip are then collected, purified by gel filtration, and UV-irradiated off-
chip to polymerize the encapsulated precursors into a hydrogel core. Hybrid 
nanoparticles of controlled size can thus be prepared in the 150 to 300 nm diameter 
range. The above approach can be extended to the assembly of other hybrid 
nanoparticle systems of interest
45
.  Microfluidic assembly may offer greater control 
over nanoparticle size and compositional requirements, as well as provide a 
systematic platform for nanoparticle characterization. 
 
5.2. EXPERIME!TAL SECTIO! 
Materials.
100
 The lipid dye 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine 
perchlorate (DiD) was obtained from Molecular Probes, and 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) and cholesterol from Avanti Polar Lipids.  
Dihexadecyl phosphate (DCP), N-isopropylacrylamide (NIPA)  (97% purity), N,N'-
methylenebis(acrylamide) (MBA) (99% purity), 2,2-diethoxyacetophenone (DEAP), 
octyl-β-D-glucopyranoside (OBG), phosphate buffered saline (PBS) pH 7.4, and 




(PDMS) (Sylgard 184) was purchased from Dow Corning.  Hamilton gas-tight glass 
syringes and anotop syringe filters were obtained from Fisher Scientific.  D-Salt 













Figure 5.2. Device schematic and optical micrograph of the microfluidic 
hydrodynamic focusing cross junction.  Microchannels were fabricated in a silicon 
substrate which was anodically bonded to a borosilicate glass cover. The microfluidic 
channel was 21±1 µm wide and 39±1 µm deep. 
 
 
Microfluidic Device Fabrication. A schematic and brightfield micrograph of the 
microfluidic device is shown in Figure 5.2.  Microfluidic devices were constructed 
using standard microfabrication processes.  A thin film of positive tone photoresist 
was spin-coated onto the front side of a double-side-polished silicon substrate wafer 
with a thickness of ~ 290 µm.  Networks of fluidic channels with widths of (21±1) 
µm (mean ± expanded uncertainty) were patterned in the photoresist using contact 




Process deep reactive ion etching to a depth of (39±1) µm (mean ± expanded 
uncertainty).  A thin film of silicon dioxide was deposited as an etch stop on the front 
side of the substrate using plasma enhanced chemical vapor deposition.  A thin film 
of positive tone photoresist was spin-coated onto the back side of the substrate and a 
second layer of contact photolithography was used to pattern access holes aligned to 
the channel inlets and outlets.  Access holes were then formed by deep reactive ion 
etching of the substrate through to the etch stop.  The substrate wafer was immersed 
in buffered hydrofluoric acid to remove the silicon dioxide etch stop and finally 
cleaned with a mixture of ammonium hydroxide:hydrogen peroxide:water (~ 5:1:1 
volume ratio) at a temperature of ~ 80 °C.  A borosilicate glass cover wafer with a 
thickness of ~ 170 µm was anodically bonded to the front side of the substrate wafer 
to form enclosed microfluidic channels.  Fluidic connectors were adhered to the back 
side of the substrate wafer to couple polyetheretherketone capillaries to the inlets and 
outlets of the microfluidic devices.  The opposing end of each inlet capillary was 
attached to a gastight glass Hamilton syringe filled with reagent.  The syringes were 
mounted onto syringe pumps (Harvard Apparatus) to control continuous fluid flow 
into the microchannels. 
 
Epifluorescence Microscopy. An inverted optical microscope was used in 
epifluorescence mode to observe microfluidic formation of nanostructures. Imaging 
was done through the cover wafer with a plan apochromat air immersion objective of 
magnification 40× and numerical aperture 0.95.  A metal halide arc lamp was used 




emission was isolated with a 660 nm dichroic mirror and refined with a 665 to 715 
nm band pass filter.  Videos and images were acquired with either an electron 
multiplying or color charge coupled device camera.  Following nanoparticle synthesis 
experiments, hybrid nanoparticles were suspended on a glass coverslip with a 
thickness of ~170 µm for inspection using the same optical setup. 
 
Buffer Preparation. 0.01 M Phosphate buffered saline (PBS) (0.138 M NaCl, 2.7 
mM KCl, pH 7.4) was used in all experiments unless otherwise specified.  PBS was 
prepared in 18.2 MΩ filtered deionized water with the addition of 3 mM NaN3 to 
prevent bacterial growth.  All PBS solutions were filtered through a 0.1 µm syringe 
filter prior to use in sample preparation. 
 
Lipid and Hydrogel Precursor Solutions. A mixture of DPPC:cholesterol:DCP 
(7:2:1 molar ratio) and 0.5 mol% DiD lipophilic tracer was used in the formation of 
the empty liposomes and lipid-hydrogel hybrid nanoparticles.   The mixture was 
dissolved in chloroform in a glass scintillation vial and was dried down under dry 
nitrogen for 45 min to produce a thin lipid film, and the dried film was placed in a 
vacuum dessicator overnight to remove any residual solvent. The NIPA:MBA:DEAP 
(3.5%:0.35%:0.1% w/v) gel precursor solution was prepared in PBS.  An Omnicure 
S2000 (EXFO Life Sciences, Canada) lamp (λ = 365 nm; 40 W cm
-2
) was used to 
initiate free-radical polymerization of the bulk hydrogel precursor material.  The 
onset of polymerization was observed immediately upon UV irradiation, and 





Precursors to Hybrid !anoparticles by Microfluidic Flow Focusing. Nanoscale 
liposomes containing hydrogel precursors were synthesized using controlled 
microfluidic mixing by hydrodynamic focusing
82
.  The lipid film was redissolved in 
dry 0.1 µm filtered IPA to obtain a 6.25 mM solution.  The lipid solution and either 
the gel precursor (experimental) or PBS (control) solution were each loaded in a glass 
syringe and connected to the device inlets, as shown in Figure 5.2.  Syringe pumps 
were used to control the flow of lipid-IPA solution into the center channel and PBS or 
gel precursor solution into the side channels to hydrodynamically focus the lipid-IPA 
stream, shown in Figure 5.1a.  Empty liposomes were formed in PBS at VFRRs of 
10:1, 15:1, 20:1, and 25:1, while liposomes encapsulating the gel precursor were 
formed at VFRRs of 10:1, 15:1, and 25:1.  The total volumetric flow rate was held 
constant at 9.6 µL min
-1 
in all cases.  Samples were collected at the device outlet for 
55 min following 10 min of stabilization at each VFRR setting. 
 
Off-Chip Formation of Hybrid !anoparticles. Liposomes encapsulating the gel 
precursor were passed through a D-Salt polyacrylamide column (6 kDa cutoff), using 
PBS as the elution buffer, to remove the extravesicular gel precursor material from 
the sample.  PDMS wells (0.625 in. diameter x 0.125 in. height) were stamped and 
cut from a cured PDMS sheet, and the wells were cleaned with ethanol followed by 
deionized water. They were dried with nitrogen before placing on a glass microscope 
slide.  0.5 mL aliquots of sample were added to each well and were irradiated with 





Light Scattering and Asymmetric Flow Field-Flow Fractionation (AF4).  An 
Eclipse Asymmetric Flow Field-Flow Fractionation (AF4) instrument integrated with 
a Dawn EOS multi-angle laser light scattering (MALLS) instrument was used for size 
fractionation and characterization of the liposomes and nanoparticles.  The AF4 
separation channel had a 190 µm spacer, and a regenerated cellulose membrane with 
a 10 kDa cutoff was used for the cross-flow partition.  For the control liposomes, 
10 mM PBS was used as the carrier solution. 10 µL of the liposome solution was 
loaded into the AF4 injection loop, and the fractionation was conducted with a 
1 mLmin
-1
 channel flow and a 0.8 mL min
-1 
to 0.0 mL min
-1
 linearly decreasing 
crossflow gradient over 70 min.  For the hybrid nanoparticles, a 5 mM PBS carrier 
solution, a 50 µL sample injection and a 0.6 mL min
-1 
to 0.0 mL min
-1
 linearly 
decreasing crossflow gradient over a 35 min elution period were used. MALLS data 
were collected simultaneously at 10 scattering angles on the eluting sample. A coated 
sphere model
83
 was applied to the data using an estimated bilayer thickness of 5 nm 
to determine the geometric radii distributions of liposomes and hybrid nanoparticles. 
 
Dynamic Light Scattering (DLS). A 90Plus/BI-MAS Particle Size Analyzer 
instrument was used for DLS measurements (Brookhaven Instruments). This 
instrument was equipped with a 15 mW solid state laser with a wavelength of 659 nm 
and measurements were made at 90° at a rate of one measurement per second.  Prior 
to conducting measurements on a nanoparticle sample, it was centrifuged at 10,000 




aspirated and diluted 1:10 in 0.02 µm filtered PBS, and the sample was added to a 
polymethylmethacrylate cuvette and placed in the measurement cell. Measurements 
were made over a series of temperatures. 
 
Transmission Electron Microscopy (TEM). TEM of the hybrid nanoparticles was 
performed on a Philips EM 400T microscope operating at 120KV equipped with a 
Soft Imaging System CCD camera (Cantega 2K).  TEM samples were prepared by 
dropping diluted solutions onto 400-mesh carbon-coated copper grids (from Ted 







5.3. RESULTS A!D DISCUSSIO! 
5.3.1. Empty Liposomes in PBS 
Empty liposomes, prepared in PBS without the hydrogel precursor, were 
synthesized in the microfluidic device as a calibration to determine the size ranges 
achieved at varying volumetric flow-rate ratios (VFRRs) with our device geometry 
and lipid formulation.  At microfluidic length-scales, the mixing of miscible liquids is 
known to occur predominantly by molecular diffusion due to the laminar flow 
conditions.  Therefore, in both the hydrodynamic focusing region and downstream in 
the diffusive mixing channel, IPA from the lipid stream will diffuse into the 
surrounding aqueous buffer stream and vice-versa. In turn, the concentration of lipid 
in the mixed liquid interface will exceed its critical aggregation concentration, 
causing the lipids to self-assemble into liposomes.  In this process, the aqueous buffer 
and its contents will get encapsulated into the aqueous liposomal core.   
 
The critical mixing time over which this self-assembly process occurs depends 
on the extent of focusing of the center stream.  At lower focusing, or smaller VFRRs, 
the center lipid-IPA stream is relatively wide with a low surface-to-volume ratio 
between the lipid stream and sheath flows, requiring a longer diffusive mixing time to 
deplete the center stream.  The prolonged lipid solubility results in the assembly of 
larger vesicles further downstream in the diffusive mixing channel while fewer 
vesicles form in the focusing region.  At higher focusing, or larger VFRRs, the center 
stream is relatively narrow, which reduces the diffusion distance and enhances 




in a higher surface-to-volume ratio and a faster depletion of the center stream.  This 
causes the self-assembly of smaller liposomes predominantly within the convective-
diffusive focusing region as opposed to the downstream mixing channel.   Control of 
these flow conditions enables predictable and repeatable production of liposomes 
with a given size distribution.   
 
In our study, we formed liposomes at VFRRs of 10:1, 15:1, 20:1 and 25:1, and 
the collected samples were then characterized by AF4-MALLS. The size distribution 
of each VFRR sample is shown in Figure 5.3a. Here, for a given sample, each data 
point represents a MALLS measurement on a size-fractionated component; thereby, 
the overall size distribution is a more accurate characterization of the sample 
compared to that obtained from traditional static or dynamic light scattering
68
. The 
size distributions show the expected trend – i.e., an increase in VFRR results in a 
smaller average size of the liposomes
22
.  For a simplified view of this trend, Figure 
5.3b plots the average radius and polydispersity vs. VFRR. In calculating these 
averages, the sizes were weighted by the number density data from Figure 5.3a.  The 
average radius and standard deviation of the distributions for the 10:1, 15:1, 20:1, and 
25:1 samples were 65 ± 6 nm, 49 ± 7 nm, 44 ± 6 nm, and 41 ± 6 nm, respectively. 
These numbers indicate that each liposome population is narrowly dispersed, 
particularly when compared to other liposome preparation techniques
82
. At high 
VFRRs (> 20:1), the size varies only slightly, suggesting that we are approaching the 






microfluidic device.  These results guided our selection of VFRR settings for the 

























Figure 5.3.  (a) Size distributions measured by AF4-MALLS of control liposome 
populations formed in PBS alone via hydrodynamic focusing at varying VFRRs. (b) 
The average outer vesicle radius and standard deviation of each population are 






















Figure 5.4. Interfacial buildup observed at the hydrodynamic focusing interface (a) 
the top of the channel, closer to the glass surface, and (b) in the middle of the channel. 
 
Liposomes encapsulating the NIPA/MBA/DEAP hydrogel precursor solution 
were formed in continuous-flow runs at VFRRs of 10:1, 15:1, and 25:1.  Compared to 
the liposomes in PBS alone, interfacial buildup (indicative of chemical 
incompatibility, such as phase separation) occurred more frequently at the 
hydrodynamic interface between the lipid and hydrogel precursor streams, especially 
closer to the borosilicate glass surface of the device (Figure 5.4). Such interfacial 
buildup was observed for all three VFRR settings but did not disrupt the directed 




problematic in trials with significantly higher hydrogel precursor concentrations (data 
not shown), which is one limitation of our technique. 
 
The liposomes collected at the outlet of the microfluidic chip was purified by 
gel filtration and then UV polymerized to yield lipid-PNIPA hybrid nanoparticles 
(Figure 5.1). The size distributions of these nanoparticle samples were then measured 
by AF4-MALLS and are shown in Figure 5.5.  The liposomes containing NIPA 
(before UV irradiation) were also characterized, and those results (Figure 5.5a) 
indicate structures with low polydispersities (comparable to empty liposomes). 
Polymerization does not alter the average size appreciably and the final lipid-PNIPA 
hybrid nanogels actually have more narrow size distributions (Figure 5.5b). This 
holds true at each of the applied VFRRs, spanning an overall size range of about 150 
to 300 nm in diameter.  The average radius and polydispersity for each VFRR is 
shown is Figure 5.6; these were (142±4) nm, (109±3) nm, and (92±5) nm for VFRRs 
of 10:1, 15:1, and 25:1, respectively.   
 
An interesting point is that, at a given VFRR, liposomes containing NIPA 
were approximately twice the size of empty liposomes (compare Figures 5.3a and 
5.5a). It is known from previous work that the liposome size obtained from 
microfluidics is sensitive to both the lipid composition as well as the presence of 
other solutes (such as dyes). Here, the presence of NIPA and other hydrogel 
precursors in the aqueous stream evidently dictates the change in size. The interfacial 




      
 





















Figure 5.5.  (a) Size distributions of lipid-NIPA liposomes; and (b) lipid-PNIPA 
hybrid nanoparticles formed by polymerizing the liposomes in (a).   
 













Figure 5.6. Average lipid-PNIPA hybrid nanoparticle size at varying VFRRs.  QGP 






























Figure 5.7.  TEM micrographs of lipid-PNIPA hybrid nanoparticles formed at 
VFRRs of (a) 10:1, (b) 15:1, and (c) 25:1. The nanoparticles exhibit characteristics of 
solid spherical structures and show a trend of decreasing size with increasing VFRR. 
 
The lipid-PNIPA hybrid nanoparticles formed by our approach showed a 
batch-to-batch reproducibility in size to within 5 % to 15 %., as measured by AF4-
MALLS. The samples were also characterized by TEM (Figure 5.7).  Each sample 
was air-dried on a TEM grid prior to imaging, and the micrographs therefore 




solid and exhibited the round shape of the liposome envelope, which confirms the 
successful encapsulation and polymerization of the hydrogel precursor within the 
liposomal interior. The particle size exhibits a decrease with an increase in VFRR, as 
earlier demonstrated by AF4-MALLS. Note that the sizes are much smaller than 
those shown in Figure 4.6, and this is evidently because of the dehydration of the 
hydrogel nanoparticles.   
 
5.3.3. Lipid-P!IPA !anoparticle Temperature Sensitivity 
 To further validate our synthesis strategy, we probed the temperature-
sensitivity of lipid-PNIPA hydrogel nanoparticles. These studies were done on 
particles synthesized at a VFRR of 10:1 using DLS. It is well-known that PNIPA 
exhibits a lower critical solution temperature (LCST) in water, and as a result, PNIPA 
hydrogels shrink when heated up to its LCST, which is ~ 32 °C. We therefore 
measured the size of lipid-PNIPA hydrogel nanoparticles over a range from 25 °C to 
32 °C, and then at 37 °C (the latter being the physiological temperature at which these 
nanoparticles may potentially be applied). Prior to measurement at a given 
temperature, care was taken to ensure that the sample had reached thermal 
equilibrium. At each temperature, three measurement runs were performed and the 
average values of the hydrodynamic diameter Dh from DLS along with the standard 
deviations are plotted in Figure 5.8.  Dh was 259.8±9.9 nm at 25 °C, 243.3±7.3 nm at 
32 °C, and at 37 °C was 224±6.7 nm.  The results show the characteristic temperature 




have been reported by Levon et al. for lipid-PNIPA hybrid particles prepared by a 
bulk method.  
 
                    
Figure 5.8.  DLS data showing the effect of increasing temperature on the 
hydrodynamic diameter Dh of lipid-PNIPA hybrid nanoparticles prepared at a VFRR 
of 10:1. 
 
 A further interesting aspect is the effect of prolonged exposure at 37 °C on 
lipid-PNIPA hydrogel nanoparticles. Corresponding size data from DLS are shown in 
Figure 5.9.  Each data point corresponds to the average Dh and standard variation 
from a 2.5 min measurement run.  After 7.5 min exposure at 37 °C, the average Dh  
increased significantly, and this is indicative of nanoparticle aggregation. Similar 
behavior has also been previously reported by Levon et al.
72
 for their bulk-prepared 
lipid-PNIPA particles. The increasing hydrophobicity of the PNIPA gel cores is 





          
Figure 5.9.  Time-lapse DLS data showing the effect of prolonged exposure to 37 °C 
on the hydrodynamic diameter Dh of lipid-PNIPA nanoparticles (VFRR of 10:1).  
  
5.3.4. Lipid-P!IPA !anoparticle Stability 
Liposome-PNIPA nanoparticles were monitored for stability after formation.  
Fluorescence micrographs of particles two weeks after formation (Figure 5.10a) 
confirm that the particles are discrete and unaggregated.  TEM measurements in 
Figure 5.10b show hybrid nanoparticles made at a VFRR 15:1 after two months.  The 
nanoparticles generally show the same solid, spherical structure as the initially 
polymerized sample shown in Figure 5.7b, further confirming their stability and 
robustness.  DLS measurements made on samples after 4 months also verified that the 
sizes remained consistent, which is likely due to the lipid bilayer coating preventing 
aggregation of the PNIPA nanogel cores. It should be noted that the DCP component 
of the lipid formulation has a negative charge, which confers electrostatic stability to 





Figure 5.10. Stability of the lipid-PNIPA hybrid nanoparticles: (a) Epifluorescence 
micrograph taken two weeks after sample formation shows that the nanoparticles 
remain unaggregated.  (b) TEM of the VFRR 15:1 sample two months after formation 
shows that the particles still retain similar structure and size, comparable to the 
original sample in Figure 5.7b. 
 
Bulk preparations of lipid-hydrogel nanoparticles typically involve the use of 
a single formulation of lipid and hydrogel precursor to produce a single vesicle 
population with a particular size distribution determined by the application of several 
size-altering post-processing steps, which can decrease yield, increase cost and 
introduce biological compatibility issues.  Using our microfluidic method, we 
synthesized relatively monodisperse populations of lipid-PNIPA hybrid nanoparticles 
from a single formulation without size-altering post-processing.  Through precise 
variation of microfluidic mixing conditions, our method should be able to produce 
nanoparticle populations with any intended size within a finite range from an initial 
formulation, limited primarily by the chemical compatibility of the precursor 
solutions at the fluidic interface.  Our approach could be useful in therapeutic agent 




materials and sizes to target different types of cells.  With the myriad of polymers and 
lipids commercially available and the interest in tailoring different types of 
nanoparticles for various applications
101
, the development of a more standardized and 
controlled formation method such as the presented model system would be 
advantageous.  We expect that this system could be adapted and optimized for the 
microfluidic-directed synthesis of hybrid nanoparticles derived from other soft matter 
precursors of present interest.  
 
5.4. CO!CLUSIO!S 
We have presented a microfluidic focusing method to direct the assembly of 
lipid-PNIPA hybrid nanoparticles.  By varying the microfluidic mixing conditions, 
we were able to control the size of the liposome molds that encapsulated the gel 
precursor, which thereby determined the sizes of the resultant hybrid nanoparticles.  
Using light scattering and TEM, we verified that our method produced narrowly-
dispersed populations of lipid-hydrogel hybrid nanoparticles over a size range 
pertinent to targeted delivery and controlled release applications.  Our method can be 
further improved through on-chip integration of the off-chip formation steps; however 
the main objective of our work is to demonstrate the utility of a microfluidic-directed 
approach towards hybrid nanoparticles.  We believe that this microfluidic approach 
may be customized for the synthesis of a wide variety of soft nanoparticles that are 





6. CO!CLUSIO!S A!D RECOMME!DATIO!S 
6.1. CO!CLUSIO!S 
 We have presented three studies that focus on the development of methods for 
the self-assembly of multiple material soft matter nanoparticles, highlighting the use 
of nanoscale phospholipid vesicles as reaction vessels for supramolecular assembly of 
nanoscale hydrogel structures.  While liposomes were previously applied in this 
capacity for the self-assembly of larger microparticle structures, few had investigated 
the use of liposomes for the synthesis of nanoparticles.  Soft matter nanoparticles are 
recognized for possessing many unique and potentially useful properties owing to 
their small size, especially in the areas of controlled release and therapeutics.   
 
 We first used liposomes to template the supramolecular assembly of calcium 
alginate gel nanoparticles using a gentle bulk synthesis procedure compared with the 
commonly applied synthesis techniques.   Liposomes were self-assembled in a 
sodium alginate precursor solution by bulk solvent-injection, and after purification 
the lipid bilayer membrane was permeabilized at its transition temperature to 
facilitate the diffusion of calcium ions from the surrounding buffer into the liposome 
core to ionically crosslink the encapsulated sodium alginate into a calcium alginate 
gel.  Upon lipid removal, the resultant nanogels were verified to be similar in size and 
shape to the original liposomes.  We further demonstrated that the size of the resultant 
gels could be tailored by modifying the initial lipid formulation, which by extension 




application, the bare calcium-alginate nanogels or the hybrid lipid-alginate 
nanoparticles could be produced. 
 
The potential improvement over size control and yield of the bulk liposome-
templated alginate nanogel preparation was investigated by adapting a microfluidic 
directed self-assembly method that was previously shown to improve the control over 
the self-assembly of nanoscale liposomes.  Modifications to the lipid and sodium 
alginate formulations were made to enable continuous formation of liposomes with 
encapsulated alginate with microfluidic hydrodynamic focusing.  By adjusting the 
microfluidic mixing conditions of the lipid and alginate precursor solutions, we 
produced three relatively monodisperse populations of liposomes with discrete size 
distributions, however the encapsulation efficiency of sodium alginate was very low. 
These findings suggested that this microfluidic self-assembly method would be better 
suited for hydrogel materials based on smaller oligomer or monomer precursor 
materials. 
 
Finally we used the microfluidic directed self-assembly method to produce 
lipid-hydrogel hybrid nanoparticles with a commonly used photopolymerizable 
hydrogel monomer-based, PNIPA.  From a single lipid and PNIPA precursor 
formulation, we produced three highly monodisperse and discrete populations of 
nanoscale liposomes encapsulating the hydrogel monomer precursor.  The liposome 
cores were UV polymerized and the resultant lipid-PNIPA hybrid nanoparticles were 




temperature-sensitive properties known of the PNIPA polymer.  We foresee the 
extension of this continuous microfluidic approach to the directed self-assembly of 
other lipid-polymer hybrid nanoparticle systems that have been limited to bulk 
synthesis methods.                     
 
6.2. RECOMME!DATIO!S FOR FUTURE WORK 
6.2.1. Microfluidic Device Optimization 
 The chemical incompatibilities we encountered at the focusing interface of the 
microfluidic channel occurred mainly at the glass surface of the device.  The channel 
depths in our device were approximately 39 µm deep, thus the effect of the several 
microns of transient buildup close to the glass surface accounted for approximately 
10% of the mixing region.  Recently we learned that with respect to microfluidic 
mixing, fabrication of microchannels with a small width-to-depth aspect ratio can 
significantly increase the uniformity of the hydrodynamic focusing interface
54
.  A 
deeper microchannel would reduce the fraction of sample that may be affected by the 
chemical incompatibilities, with the added advantage of increased sample output with 
little sample dilution
82
.  Alternatively, increasing the channel width would also lead to 
a higher sample throughput, but with a lower resultant nanoparticle concentration due 
to the higher VFRRs required to achieve the same focusing conditions as a device 
with a smaller channel width.  We believe that these device modifications would 
greatly improve device robustness and reusability, while also improving ease of 





6.2.2. Formulation Optimization for Microfluidic Directed Synthesis 
 We studied several formulations for the self-assembly of lipid-PNIPA 
nanoparticles, however a more systematic investigation into the effect of initial lipid 
and hydrogel precursor formulations on the resultant hybrid nanoparticle population 
size and composition would be useful.  The duration of UV polymerization required 
for gelation of the encapsulated hydrogel precursor should also be optimized to the 
shortest time required for free radical polymerization.  These studies would improve 
the efficiency and applicability of our method. 
 
The polymerization of PNIPA can be initiated with several different 
photoinitiators as well as chemical initiators.  Chemical initiators, such as the strong 
oxidizer ammonium persulfate, have been used for polymerization of PNIPA but they 
tend to be highly toxic and therefore an unfavorable choice for our intended 
applications.  In Chapter 5 we used a small quantity of DEAP, a significantly less 
toxic hydrophobic photoinitiator, which was sufficient in initiating polymerization but 
had limited solubility in the hydrogel precursor solution that was composed of 
hydrophilic monomers.  The next formulation improvement might be to use a 
hydrophilic photoinitiator such as riboflavin, a photosensitive vitamin that has been 
used in the polymerization of acrylamide
102
.   
 
An alternative photoinitiator  to try would be 2-hydroxy-1-[4-[2-
hydroxyethoxy)phenyl]-2-methyl-1-propanone  (Irgacure 2959), which is most 




or tissue engineering research
103
,  which has been found to be the least harmful  to a 
broad range of mammalian cell types compared to others
104-107
.  Irgacure 2959 can 
also be used in a lower concentration than the DEAP, potentially improving the 
solubility in the hydrogel precursor mixture.  With a more soluble photoinitiator we 
may be able to optimize the concentration used to reduce the polymerization time 
required for the formation of PNIPA. 
   
6.2.3. Integration of Off-Chip Processing Steps 
 Our work has focused on the initial microfluidic mixing self-assembly step, 
which is perhaps the most critical in determining the size and composition of the 
resultant nanoparticles.  However the ultimate goal is to completely automate this 
method, which would require the integration of the sample purification and free 
radical polymerization steps on-chip.  One possible method for sample purification 
would involve adding several rinsing steps to the device to dilute the vesicles 
downstream after self-assembly and encapsulation.  The unencapsulated hydrogel 
precursor molecules would diffuse outward into the fresh buffer while the larger 
liposomes would remain focused in center of the mixing channel due to their smaller 
diffusion coefficients.  Following the purification step, UV irradiation of the sample 
would be integrated downstream.       
 
6.2.4. Encapsulation of Model Drug 
 We have demonstrated a method that produces highly monodisperse hybrid 




a fluorescent dye or a protein such as bovine serum albumin.  We believe our particle 
synthesis method is relatively gentle, however the hydrogel precursor solution is 
known to be toxic, and therefore the effect on encapsulated biomolecules must be 
investigated.  An alternative, less toxic method of encapsulation may be to template 
the hydrogel nanoparticles first, incubate them with the encapsulant of interest, and 
then re-attach a lipid shell around the nanogel.  This would promote uniform 
encapsulation and structure of the particles, which is critical for precise controlled 
release.    
 
6.2.5. Cellular !anotoxicity 
  PNIPA has been studied extensively for its unique thermosensitive material 
properties that are considered to be potentially useful for the triggered release of 
drugs near physiological temperatures
104,108
.  To this end, it is important to understand 
the interactions these liposome-PNIPA nanoparticles have with cells and the potential 
limitations associated with their application.  It is well-known that size is a critical 
parameter in determining the fate of nanoparticles when using them for targeted 
delivery or controlled release.  The microfluidic approach we have demonstrated 
would enable us to systematically study the effects that varying nanoparticle size, 
composition, and concentration may have on cellular uptake, metabolic processes, 
and cell viability.  This type of toxicity data is badly needed before the practical 








6.2.6. Additional Soft Hybrid Systems 
 One main goal in developing this microfluidic system is to have an adaptable 
method for the formation of other hybrid nanoparticle systems.  Within our current 
lipid-PNIPA system, the overall attainable size range of the nanoparticles could be 
adjusted by changing the initial lipid formulation, which would translate into a 
different liposome template size due to the fundamentally altered self-assembly 
conditions.       
 
Given the results of the microfluidic directed synthesis of lipid-alginate hybrid 
nanoparticles, our method may be limited to hydrogel materials based on small 
monomer gel precursors or oligomers of known molecular weight that can be 
crosslinked into a supramolecular assembly.  Within this subclass of materials, there 
are still large number relevant to the synthesis of particles for pharmaceutical 
applications that we could investigate
45
, including photopolymerizable materials.   
 
One particular material of interest is poly(ethylene glycol) diacrylate (PEG-
DA), which can be obtained at relatively small known molecular weights and has 
been used to synthesize lipid-PEG hybrid nanoparticles
93
.  PEG-DA, a derivative of 
PEG, is a familiar nontoxic polymer currently used in a number of drug delivery and 
cell-based studies.  PEG-DA can also be functionalized with a variety of molecules 
such as peptides, which offers another degree of versatility when considering the 
design of a nanoparticle delivery system.
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